Nebius Stock Surges on $27B Meta Deal, but Execution Risks Loom Large

What happened

Nebius Group's stock surged over 14% to $130 in extended hours after landing a $27 billion deal from Meta Platforms, its highest point since November last year. This rally occurs amidst a volatile trading history, with the DeepValue report noting a 'WAIT' rating at $112.95 due to high execution and financial risks. The report emphasizes that deal headlines often distract from Nebius's critical need to ramp connected power to 800 MW–1 GW by year-end 2026 to support its $7B–$9B ARR guide. Key vulnerabilities include termination rights in Microsoft's $17.4B contract if delivery slips and dilution from NVIDIA's $2B warrant, which adds 21 million shares. Therefore, while the Meta deal bolsters contracted demand, investors must focus on upcoming quarterly disclosures of power throughput and dilution metrics to assess true viability.

Implication

This news may temporarily inflate the stock price, but the DeepValue report underscores that Nebius's valuation hinges on delivering connected power and managing dilution, not just securing deals. Investors should closely monitor the next two quarters for connected power acceleration and warrant dilution staying below 5%, as these are critical proof points. A failure to meet delivery timelines could trigger contract terminations, severely impacting revenue and undermining the investment thesis. Until these operational milestones are confirmed, maintaining a 'WAIT' stance with an attractive entry at $90 is recommended to avoid overpaying. Consider re-evaluating only if quarterly data shows sustained progress and controlled share issuance.

Thesis delta

The Meta deal adds to Nebius's contracted backlog but does not alter the core investment thesis centered on execution risks and financial overhangs. No material shift is warranted; the 'WAIT' rating and key checkpoints, such as monitoring connected power ramp and dilution management, remain fully applicable. Investors should view this news as a demand-side validation that does not change the need for cautious, data-driven assessment.